Showing results (81-90 of 88) with videos related to
Sort By:
Pageof 9
You have reached the last page of results.This site can display upto 88 results.
Lancet (London, England)|April 22, 1995
Insertion/deletion polymorphism in the angiotensin-converting enzyme gene and risk of restenosis after coronary angioplastyN J Samani, D S Martin, M Brack, et al.Lancet (London, England)|November 2, 1985
Double-blind randomised trial of intravenous tissue-type plasminogen activator versus placebo in acute myocardial infarctionM Verstraete, W Bleifeld, R W Brower, et al.Lancet (London, England)|January 30, 1988
Thrombolysis with tissue plasminogen activator in acute myocardial infarction: no additional benefit from immediate percutaneous coronary angioplastyM L Simoons, A E Arnold, A Betriu, et al.British Heart Journal|February 1, 1992
Effect of early intravenous heparin on coronary patency, infarct size, and bleeding complications after alteplase thrombolysis: results of a randomised double blind European Cooperative Study Group trialD P de Bono, M L Simoons, J Tijssen, et al.The American Journal of Cardiology|August 1, 1987
Acute coronary thrombolysis with recombinant human tissue-type plasminogen activator: initial patency and influence of maintained infusion on reocclusion rateM Verstraete, A E Arnold, R W Brower, et al.European Heart Journal|November 1, 1987
Effect of continued rt-PA administration on the residual stenosis after initially successful recanalization in acute myocardial infarction--a quantitative coronary angiography study of a randomized trialP W Serruys, A E Arnold, R W Brower, et al.Atherosclerosis|September 6, 1996
Apolipoprotein E polymorphism does not predict risk of restenosis after coronary angioplastyN J Samani, D S Martin, M Brack, et al.Journal of Molecular and Cellular Cardiology|March 19, 2015
Experimental heart failure modelled by the cardiomyocyte-specific loss of an epigenome modifier, DNMT3BA Vujic, E L Robinson, M Ito, et al.Pageof 9